Olympus Corporation

Continuing Medical Education Market by Revenue to Reach USD 11.57 Billion by 2026 - Arizton

Retrieved on: 
Wednesday, December 8, 2021

CHICAGO, Dec. 8, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this continuing medical education market report.

Key Points: 
  • CHICAGO, Dec. 8, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this continuing medical education market report.
  • The continuing medical education market is expected to grow at a CAGR of over 6.7% during the period 20202026.
  • Innovative methods of continuing medical education (CME) platforms are being introduced in the market.
  • Increasing adoption of digital learning and online platforms are driving the growth of the medical education market in North America.

Continuing Medical Education Market by Revenue to Reach USD 11.57 Billion by 2026 - Arizton

Retrieved on: 
Wednesday, December 8, 2021

CHICAGO, Dec. 8, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this continuing medical education market report.

Key Points: 
  • CHICAGO, Dec. 8, 2021 /PRNewswire/ -- In-depth analysis and data-driven insights on the impact of COVID-19 included in this continuing medical education market report.
  • The continuing medical education market is expected to grow at a CAGR of over 6.7% during the period 20202026.
  • Innovative methods of continuing medical education (CME) platforms are being introduced in the market.
  • Increasing adoption of digital learning and online platforms are driving the growth of the medical education market in North America.

Olympus Sets Sights on Growth in Its Refocused Medical Business

Retrieved on: 
Tuesday, December 7, 2021

Olympus Corporation (Olympus Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi), has clarified the direction of its medical business with the aim of achieving further growth and profitability by elevating the standard of care in targeted disease states.

Key Points: 
  • Olympus Corporation (Olympus Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi), has clarified the direction of its medical business with the aim of achieving further growth and profitability by elevating the standard of care in targeted disease states.
  • Other medical areas will remain important business components and support Olympus goal of striving for greater profitability, contributing to the company-wide goal of at least 5-6% annual growth and an operating profit margin of 20% or higher.
  • Merger and acquisition momentum is expected to stay strong via the Olympus business development function, which drove significant acquisitions over the past 2 years.
  • Since 2019, Olympus has completed the sale of its Imaging business and announced the impending transition of its Scientific Solutions business into a newly established, wholly owned subsidiary.

Worldwide Endoscopes Industry to 2026 - Featuring Olympus, Johnson & Johnson and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, November 29, 2021

Intense competition among endoscopes makers exists due to the increasing demand for endoscopes for various diagnostic and therapeutic procedures, coupled with technological advances.

Key Points: 
  • Intense competition among endoscopes makers exists due to the increasing demand for endoscopes for various diagnostic and therapeutic procedures, coupled with technological advances.
  • Rising prevalence of chronic diseases, increasing adoption of endoscopes for treatment and diagnosis, and technological advancements leading to enhanced applications of endoscopes.
  • One of the global leaders in medical devices industry, Olympus Corporation has focused on endoscopes innovation and some strategic M&A activity.
  • The report analyses the Endoscopes Market by Product Type (Flexible Endoscopes, Rigid Endoscopes and Others).

At 8.63% CAGR, Action Camera Market Size is Projected to reach USD 4116.2 Mn by 2027, Says Brandessence Market Research

Retrieved on: 
Monday, November 22, 2021

LONDON, Nov. 22, 2021 /PRNewswire/ -- According to Brandessence Market Research, the global action camera market size reached USD 2310.4 million valuation in 2020.The action camera market size is likely to reach USD 4116.2 million by 2027 end, rising at 8.63% CAGR by 2027 end.

Key Points: 
  • LONDON, Nov. 22, 2021 /PRNewswire/ -- According to Brandessence Market Research, the global action camera market size reached USD 2310.4 million valuation in 2020.The action camera market size is likely to reach USD 4116.2 million by 2027 end, rising at 8.63% CAGR by 2027 end.
  • Action camera, also known as action cam is a simple digital camera, which is known for its ability to capture adventure in action.
  • Continuous advancements in new features to make action cameras an enticing prospect to consumers remains a key necessity for growth in action camera market.
  • The growth of action cameras in major leagues like NFL is a promising sign for the commercial growth of the action camera market.

At 8.63% CAGR, Action Camera Market Size is Projected to reach USD 4116.2 Mn by 2027, Says Brandessence Market Research

Retrieved on: 
Monday, November 22, 2021

LONDON, Nov. 22, 2021 /PRNewswire/ -- According to Brandessence Market Research, the global action camera market size reached USD 2310.4 million valuation in 2020.The action camera market size is likely to reach USD 4116.2 million by 2027 end, rising at 8.63% CAGR by 2027 end.

Key Points: 
  • LONDON, Nov. 22, 2021 /PRNewswire/ -- According to Brandessence Market Research, the global action camera market size reached USD 2310.4 million valuation in 2020.The action camera market size is likely to reach USD 4116.2 million by 2027 end, rising at 8.63% CAGR by 2027 end.
  • Action camera, also known as action cam is a simple digital camera, which is known for its ability to capture adventure in action.
  • Continuous advancements in new features to make action cameras an enticing prospect to consumers remains a key necessity for growth in action camera market.
  • The growth of action cameras in major leagues like NFL is a promising sign for the commercial growth of the action camera market.

Global Digital Pathology Market Share, Size, Trends, Industry Analysis & Forecasts Report, 2021-2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, November 12, 2021

The "Digital Pathology Market Share, Size, Trends, Industry Analysis Report, By Application; By End-Use; By Product; By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Digital Pathology Market Share, Size, Trends, Industry Analysis Report, By Application; By End-Use; By Product; By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • The global digital pathology market size is expected to reach USD 1.44 billion by 2028.
  • Advancements in micro-arrays and incorporation of predictive models using API algorithms and innovations in data analysis are expected to fuel the market growth for digital pathology.
  • These benefits are projected to fuel demand in digital pathology systems in the forthcoming years.

Olympus Launches Venture Capital Fund To Strengthen Medtech Leadership

Retrieved on: 
Thursday, November 11, 2021

Olympus Innovation Ventures, a fully owned subsidiary of Olympus Corporation of the Americas, is a venture capital fund focused on startups poised to improve patient outcomes, radically advance the detection and treatment of disease, and transform the surgery suite.

Key Points: 
  • Olympus Innovation Ventures, a fully owned subsidiary of Olympus Corporation of the Americas, is a venture capital fund focused on startups poised to improve patient outcomes, radically advance the detection and treatment of disease, and transform the surgery suite.
  • The new fund expands upon Olympus' strategy to strengthen endoscopy and pioneer next-generation tools and procedures for minimally invasive surgery.
  • Olympus' venture fund is stage-agnostic, prioritizing early- and growth-stage companies globally with solutions in therapeutic areas including gastroenterology, respiratory, and urology.
  • Touchdown Ventures, a firm specializing in corporate venture capital, will help manage the Olympus Innovation Ventures fund.

Olympus Recognized as an Adoption- and Military-Friendly Employer

Retrieved on: 
Thursday, November 11, 2021

Olympus earned the 2022 Military FriendlyEmployer designation, marking the fifth consecutive year the company has received the designation.

Key Points: 
  • Olympus earned the 2022 Military FriendlyEmployer designation, marking the fifth consecutive year the company has received the designation.
  • Olympus also earned the 2022 Military Friendly Spouse Employer designation for the first time and announced its new partnership with the Wounded Warrior Program.
  • Olympus has also been named to the 2021 Dave Thomas Foundation for Adoption's annual list of America's Best Adoption-Friendly Workplaces for the fourth consecutive year.
  • Companies earning the Military Friendly Employer Designation were evaluated using both public data sources and responses from a proprietary survey.

Live Cell Imaging Markets - Global Forecast to 2027: Market is Anticipated to Grow at the Rate of 8.9% - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 3, 2021

Many researchers have broadly accepted the technology of live cell imaging to gain better knowledge about cell biology in the past few years.

Key Points: 
  • Many researchers have broadly accepted the technology of live cell imaging to gain better knowledge about cell biology in the past few years.
  • However, the cost of implementing live cell imaging is huge, which is acting as a constraint for the market growth.
  • Moreover, cell biologists use live cell imaging to understand the basic cellular structures and their interaction on the tissue level.
  • Escalating demand of live cell imaging systems in drug discovery and government investments for evolution and advancements in live cell imaging systems are few major factors driving the growth of the global live cell imaging market.